Eileen Ambing

Scientist at Interline Therapeutics

Eileen brings twenty years of industry experience with extensive knowledge in the gene to structure pipeline (molecular biology, protein expression and purification, and crystallization). Eileen was previously employed with Maze Therapeutics where she was responsible for protein expression in multiple expression systems and purification of targets across the entire drug discovery portfolio (crystallization, cryo-EM, biophysical and biochemical assays, DEL screening). When not working in the lab, Eileen enjoys surfing, snowboarding, and occasionally cruising around on her motorcycle.

Links

Previous companies

Novartis logo

Timeline

  • Scientist

    November 1, 2022 - present

  • Principal Research Associate

    June 1, 2022

View in org chart